BioAtla, Inc. (BCAB) stock
BCABOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$1.31−0.05 (-3.68%)
Close on Oct 19, 2026Market cap $2.18MP/E –Yield –
BioAtla enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
BioAtla's enterprise value was $634.90K on Oct 19, 2026, against $22.86M a year earlier. Over the last 5 years it ranged from -$132.93M to $618.63M, with a median of -$1.77M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $634.90K | -97.5% |
| 2025 | Dec 31, 2025 | $25.06M | – |
| 2024 | Dec 31, 2024 | -$27.93M | – |
| 2023 | Dec 29, 2023 | -$23.43M | -119.2% |
| 2022 | Dec 30, 2022 | $121.89M | -71.0% |
| 2021 | Dec 31, 2021 | $420.86M | – |
See a number that looks wrong?